CTMX CytomX Therapeutics, Inc. logo

CTMX CytomX Therapeutics, Inc.

Healthcare
$3.76+0.00%ClosedMarket Cap: $604.7M

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

130

13F Shares

144,058,109

Ownership %

87.3%

New Positions

39

Increased Positions

77

Closed Positions

21

Reduced Positions

27

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
FMEDFidelity Disruptive Medicine ETF112,0690.92%
BBCVirtus Biotech Clinical Trials ETF65,0800.87%
CANCTema Oncology ETF226,0230.64%
IDNAiShares Genomics Immunology and Healthcare ETF206,3620.63%
QQQSInvesco NASDAQ Future Gen 200 ETF13,1700.46%
XBI4,511,0360.29%
BFORBarron's 400SM ETF105,8200.24%
LABUDirexion Daily S&P Biotech Bull 3X ETF225,6450.20%
IBBiShares Biotechnology ETF987,3970.06%
EESWisdomTree U.S. SmallCap Fund69,4760.05%
VSTCX157,4490.03%
VEXPX642,0750.01%
VEXRX642,0750.01%
FHLCFidelity MSCI Health Care Index ETF72,9680.01%
DFASDimensional - US Small Cap ETF297,3210.01%
TECBiShares U.S. Tech Breakthrough Multisector ETF12,6550.01%
VEXAX1,459,3940.01%
VXF1,459,3940.01%
VIEIX1,459,3940.01%
VEMPX1,459,3940.01%